🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →
Business news, market intelligence, and global industry analysis.
The Latest

AstraZeneca closes acquisition of cell therapy company Neogene Therapeutics

byPallavi Madhiraju
January 17, 2023
AstraZeneca closes acquisition of cell therapy company Neogene Therapeutics
AstraZeneca closes acquisition of cell therapy company Neogene Therapeutics. Photo courtesy of D Wells/Wikimedia Commons.
Total
0
Shares
0
0
0

Pharma giant AstraZeneca has closed the previously announced acquisition of Neogene Therapeutics, a US-based clinical-stage biotechnology company.

Neogene Therapeutics is engaged in the discovery, development, and manufacturing of next-generation T-cell receptor therapies (TCR-Ts).

AstraZeneca announced the deal to acquire the cell therapy company in November 2022 and offered a consideration of up to $320 million.

Neogene Therapeutics will now work as a fully-owned subsidiary of the pharma giant, with operations in Amsterdam and California.

AstraZeneca closes acquisition of cell therapy company Neogene Therapeutics
AstraZeneca closes acquisition of cell therapy company Neogene Therapeutics. Photo courtesy of D Wells/Wikimedia Commons.

Recently, AstraZeneca signed a deal to acquire CinCor Pharma, a US-based clinical-stage biopharmaceutical company, for a transaction value of about $1.8 billion.

Discover more from Business-News-Today.com

Subscribe to get the latest posts sent to your email.

See also  Lantern Pharma gets FDA nod for Harmonic phase 2 clinical trial of LP-300
Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Gilead Sciences announces Biktarvy China approval for HIV-1

Biktarvy China approval : US biopharma company Gilead Sciences said that the China National Medical Products Administration (NMPA) has approved Biktarvy (bictegravir 50mg/emtricitabine 200mg/tenofovir alafenamide 25mg, BIC/FTC/TAF) for the treatment of HIV-1 infection. The once-daily single tablet regimen (STR) Biktarvy is a combination of the unboosted integrase strand transfer inhibitor (INSTI) bictegravir and the dual […]

The post Gilead Sciences announces Biktarvy China approval for HIV-1 appeared first on PharmaNewsDaily.com.

bypharmanewsdaily
Read More

Sound Pharmaceuticals bags FDA fast track status for SPI-1005 in Meniere’s Disease

US biopharma company Sound Pharmaceuticals said that its investigational drug SPI-1005 has secured the fast track designation (FTD) from the US Food and Drug Administration (FDA) for the treatment of Meniere’s Disease (MD), a disorder of the inner ear. The FTD was granted by the FTD’s Division of Neurology Products, which is for drugs that can […]

The post Sound Pharmaceuticals bags FDA fast track status for SPI-1005 in Meniere’s Disease appeared first on PharmaNewsDaily.com.

bypharmanewsdaily